“Estimation of Midkine Levels in Gingival Crevicular Fluid and Serum in Periodontal Health, Disease and After Treatment” − A Clinico Biochemical Study

Abstract

Introduction: The objective of the present study was to evaluate the role of Midkine in periodontal disease progression and also to investigate the effect of periodontal therapy on Midkine concentration in serum and gingival crevicular fluid (GCF). Materials and Methods: Clinical parameters including gingival index, pocket probing depth, clinical attachment level were recorded for 60 subjects divided into four equal groups Group I (healthy), Group II (gingivitis), Group III (chronic periodontitis), and Group IV (post treatment group). Scaling and root planning were performed and GCF and serum were collected initially and after 8 weeks of treatment. Midkine levels were estimated using enzyme-linked immunosorbent assay. Results: The mean Midkine concentration in GCF and serum was found to be the highest in group III, and significantly defers from group-I, II, and IV. The results of present study also suggest that Midkine levels increased progressively in GCF and serum from healthy to periodontitis subjects and levels decreased considerably after scaling and root planning. Conclusion: As the periodontal disease progresses, there is a substantial increase of Midkine concentrations in serum and GCF. The data indicate that high GCF and serum levels of Midkine are at significantly greater risk for progression of periodontitis However, controlled, longitudinal studies are needed to confirm this possibility.